JONATHAN SHAW: Open Payments
NPI 1023641743 · EUGENE, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$198 in 9 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $122 · 2025 $198
Food & beverage: $198
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 2 | $47 |
| E.R. Squibb & Sons, L.L.C. | 2 | $40 |
| ABBVIE INC. | 1 | $32 |
| Axsome Therapeutics, Inc. | 1 | $26 |
| Vanda Pharmaceuticals Inc. | 1 | $19 |
| Alkermes, Inc. | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
Products named: COBENFY, VRAYLAR, ABILIFY MAINTENA, Auvelity, FANAPT, ARISTADA, AUSTEDO XR, REXULTI.
Industry payments across OR — which companies pay providers there.
